Aclaris Therapeutics (8AT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ati-045 | Atopic Dermatitis, Dermatitis, Eczema, Atopic, Ad | Phase II | Recruiting | ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis | May 27, 2025 | ― |
| Ati-2138 | Atopic Dermatitis | Phase II | Completed | Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis | Sep 03, 2024 | ― |
| Ati-450 | Psoriatic Arthritis | Phase II | Terminated | Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis | Jul 29, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ati-045 | Phase II | Atopic Dermatitis, Dermatitis, Eczema, Atopic, Ad | Recruiting | ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis | May 27, 2025 | ― |
| Ati-2138 | Phase II | Atopic Dermatitis | Completed | Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis | Sep 03, 2024 | ― |
| Ati-450 | Phase II | Psoriatic Arthritis | Terminated | Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis | Jul 29, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Aclaris Therapeutics Inc. (DE:8AT) have in its pipeline
Aclaris Therapeutics DE:8AT is currently developing the following drugs: Ati-045, Ati-2138, Ati-450. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
